Polypill use for the prevention of cardiovascular disease: A position paper
Rev Port Cardiol. 2023 Oct;42(10):861-872.
doi: 10.1016/j.repc.2023.02.011.
Epub 2023 May 10.
[Article in
English,
Portuguese]
Authors
Francisco Araújo
1
, Daniel Caldeira
2
, Carlos Aguiar
3
, José Pedro Antunes
4
, Nuno Cardim
5
, Vitória Cunha
6
, Luísa Fonseca
7
, José P Moura
8
, Vitor M Paixão-Dias
9
, Hugo Ribeiro
10
, Vitor Tedim Cruz
11
, Cristina Gavina
12
Affiliations
- 1 Departamento Medicina Interna, Hospital dos Lusíadas, Lisboa, Portugal. Electronic address: faraujoster@gmail.com.
- 2 Centro Cardiovascular da Universidade de Lisboa - CCUL, CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal; Cardiology Department, Hospital Universitário de Santa Maria - CHULN, Portugal; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Portugal.
- 3 Cardiology Department, Hospital de Santa Cruz, Centro Hospitalar Lisboa Ocidental, Portugal.
- 4 Unidade de Saúde Familiar Arte Nova, Agrupamento Centros de Saúde Baixo Vouga, Aveiro, Portugal.
- 5 Cardiology Department, Hospital da CUF, Lisboa, Portugal.
- 6 Hospital Garcia de Orta, Almada, Portugal.
- 7 Stroke Unit, Internal Medicine Department, Centro Hospitalar Universitário S. João, Faculty of Medicine of the University of Porto, Portugal.
- 8 Department of Internal Medicine, University Hospital of Coimbra, Coimbra, Portugal.
- 9 ESH Hypertension Excellence Center of the Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, EPE, Portugal.
- 10 Palliative Care Unit of ACES Gaia and Faculty of Medicine of Universidade do Porto, Porto, Portugal; Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR) - Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, Coimbra, Portugal.
- 11 EPIUnit - Instituto de Saúde Pública, Portugal; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Universidade do Porto, Porto, Portugal; Serviço de Neurologia, Departamento de Medicina, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal.
- 12 Serviço de Cardiologia, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal; Departamento de Medicina, Faculdade de Medicina da Universidade do Porto, UnIC, Cardiovascular Research Center, Portugal.
Abstract
Cardiovascular (CV) guidelines stress the need for global intervention to manage risk factors and reduce the risk of major vascular events. Growing evidence supports the use of polypill as a strategy to prevent cerebral and cardiovascular disease, however it is still underused in clinical practice. This paper presents an expert consensus aimed to summarize the data regarding polypill use. The authors consider the benefits of polypill and the significant claims for clinical applicability. Potential advantages and disadvantages, data regarding several populations in primary and secondary prevention, and pharmacoeconomic data are also addressed.
Keywords:
Cardiovascular; Consenso; Consensus; Polipílula; Polypill; Prevention; Prevenção; Primary; Primária; Secondary; Secundária.
Copyright © 2023 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.